Alnylam Pharmaceuticals Inc (ALNY): Eigentümerstruktur
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 367,778 US Dollar | 17 | 6 | 7 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 133.809.118 | 6,54 | 5,02 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Alnylam Pharmaceuticals Inc
Mitarbeiter 2.500
Handelsplatz NASDAQ
Ticker Symbol ALNY
IPO Datum 2004-05-28
Adresse 675 West Kendall Street, Cambridge, MA, United States, 02142
Webseite https://www.alnylam.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Yvonne L. Greenstreet M.B.A., M.D. | CEO & Director |
| 2 | Dr. Phillip A. Sharp Ph.D. | Co-Founder, Member of the Scientific Advisory Board |
| 3 | Mr. Jeffrey V. Poulton M.B.A. | CFO & Executive VP |
| 4 | Mr. Bryan Andrew Supran J.D. | Chief Legal Officer |
| 5 | Dr. Pushkal P. Garg M.D. | Executive VP & Chief Research & Development Officer |
| 6 | Mr. Tolga Tanguler M.B.A. | Executive VP & Chief Commercialization Officer |
| 7 | Mr. Timothy J. Maines | Chief Technical Operations & Quality Officer |
| 8 | Dr. Kevin Joseph Fitzgerald Ph.D. | Executive VP, Chief Scientific Officer and Head of Early Research & Early Development |
| 9 | Mr. Joshua Brodsky | Vice President of Investor Relations |
| 10 | Mr. Piyush Sharma J.D. | Chief Ethics & Compliance Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | FMR Inc | 11,23% | 3,49 Mrd. USD |
| 2 | Capital World Investors | 8,33% | 2,59 Mrd. USD |
| 3 | BlackRock Inc | 8,15% | 2,54 Mrd. USD |
| 4 | Capital Research Global Investors | 7,29% | 2,27 Mrd. USD |
| 5 | Vanguard Portfolio Management, LLC | 4,89% | 1,52 Mrd. USD |
| 6 | Vanguard Capital Management, LLC | 4,51% | 1,40 Mrd. USD |
| 7 | T. Rowe Price Investment Management,Inc. | 4,22% | 1,31 Mrd. USD |
| 8 | Amvescap Plc. | 2,81% | 0,87 Mrd. USD |
| 9 | State Street Corp | 2,66% | 0,83 Mrd. USD |
| 10 | JPMorgan Chase & Co | 2,00% | 0,62 Mrd. USD |
| 11 | Geode Capital Management, LLC | 1,97% | 0,61 Mrd. USD |
| 12 | Baillie Gifford & Co Limited. | 1,82% | 0,57 Mrd. USD |
| 13 | NORGES BANK | 1,70% | 0,53 Mrd. USD |
| 14 | Wellington Management Company LLP | 1,58% | 0,49 Mrd. USD |
| 15 | Orbis Allan Gray Ltd | 1,49% | 0,46 Mrd. USD |
| 16 | Dodge & Cox | 1,46% | 0,45 Mrd. USD |
| 17 | Two Sigma Investments LLC | 1,40% | 0,44 Mrd. USD |
| 18 | American Century Companies Inc | 1,39% | 0,43 Mrd. USD |
| 19 | ClearBridge Advisors, LLC | 0,94% | 0,29 Mrd. USD |
| 20 | T. Rowe Price Associates, Inc. | 0,86% | 0,27 Mrd. USD |